AGAM
GSK icon

Avalon Global Asset Management’s GSK GSK Stock Holding History

Avalon Global Asset Management’s Portfolio GSK Stock Details GSK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		– Sell
-52,000
Closed -$2.8M – 40
2016
Q3 		$2.8M Buy
+52,000
New +$2.85M 1.68% 31

Other funds holding GSK

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
Hotchkis & Wiley Capital Management
Hotchkis & Wiley Capital Management Los Angeles, California $32.4B AUM 17.21% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Avalon Global Asset Management's GSK Position: Q4 2016 in Review

Avalon Global Asset Management sold out of GSK (GSK) in Q4 2016, closing a stake of 52,000 shares — an estimated $2.8M sold.

Avalon Global Asset Management first reported a position in GSK in Q3 2016 and held it in 1 quarter. The position peaked at $2.8M in Q3 2016. 763 funds tracked by Wall St. Rank hold GSK as of Q4 2016.

  • Avalon Global Asset Management reported no remaining GSK position as of Q4 2016 after selling out during the quarter.
  • Avalon Global Asset Management sold 52,000 GSK shares in Q4 2016, an estimated $2.8M.
  • Avalon Global Asset Management first reported a position in GSK in Q3 2016 and held it in 1 quarter.
  • Avalon Global Asset Management's GSK position peaked at $2.8M in Q3 2016.
  • 763 funds tracked by Wall St. Rank held GSK as of Q4 2016.

Based on Avalon Global Asset Management's 13F filing for Q4 2016, filed 13 Feb 2017.